Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 9Neoplasms 5Lung Neoplasms 5Neuroendocrine Tumors 4Melanoma 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Pancreatic Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Extranodal NK-T-Cell 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Vasculitis 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Toxemia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Solid Tumor, Adult 1Smoking Cessation 1Sezary Syndrome 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Positron-Emission Tomography × Clear all
NCT02018107 2020-03-26

PET/CT-Assessment of Liver Tumor Ablation

Dana-Farber Cancer Institute

Phase NA Completed
33 enrolled 5 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡